日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular Insights for Precision Care in Cardiovascular Disease: Perspectives from the Special Issue

心血管疾病精准治疗的分子机制:特刊观点

Terasaki, Michishige; Yamagishi, Sho-Ichi

A DYRK inhibitor ameliorates glucose homeostasis and increases incretin-producing cells in diabetic mice.

DYRK 抑制剂可改善糖尿病小鼠的葡萄糖稳态并增加肠促胰岛素产生细胞。

Terasaki Michishige, Zhou Qiao, Andersson Olov, Yamagishi Sho-Ichi

Casein- and Soy-Based High-Protein Diets Differentially Affect Insulin Resistance and Adipose Tissue Advanced Glycation End Product Accumulation in Obese Diabetic Mice.

酪蛋白和大豆基高蛋白饮食对肥胖糖尿病小鼠的胰岛素抵抗和脂肪组织晚期糖基化终产物积累的影响不同。

Shiraga Yoshie, Mori Yusaku, Osaka Naoya, Terasaki Michishige, Yashima Hironori, Saito Tomomi, Tanno Daiki, Ogino Madoka, Ohara Makoto, Yamagishi Sho-Ichi

Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study

培马贝特可增加循环中血管生成素样蛋白3和4的水平,而不会促进低密度脂蛋白和高密度脂蛋白亚组分发生促动脉粥样硬化的变化:PRESTIGE研究的事后分析

Hirano, Tsutomu; Hayashi, Toshiyuki; Sugita, Hiroe; Tamasawa, Atsuko; Ohara, Makoto; Terasaki, Michishige; Ito, Yasuki; Yamagishi, Sho-Ichi; Mori, Yusaku

Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant

针对人TMPRSS2的单克隆抗体可预防任何SARS-CoV-2变种的感染

Michishige Harada,Takehisa Matsumoto,Mizuki Yamamoto,Jin Goda,Akiko Idei,Kenichi Ohtaki,Natsuki Kojima,Natsumi Yoneda,Kosuke Miyauchi,Kazushige Katsura,Mariko Ikeda,Kazuharu Hanada,Yoshiko Ishizuka-Katsura,Toshiaki Hosaka,Tamao Hisano,Toshie Kaizuka,Takako Yamamoto,Masashi Matsuda,Manabu Nakayama,Akiko Sugimoto-Ishige,Machie Sakuma,Rina Hashimoto,Kazuo Takayama,Misako Nakayama,Cong Thanh Nguyen,Hirohito Ishigaki,Yasushi Itoh,Yoshinobu Hashizume,Minoru Yoshida,Yasushi Kawaguchi,Makoto Takeda,Haruhiko Koseki,Mikako Shirouzu,Jun-Ichiro Inoue,Takashi Saito

Association of glycemic variability with oxidative stress and AGE accumulation in type 2 diabetes

血糖波动与2型糖尿病患者氧化应激和AGE积累的相关性

Ohara, Makoto; Takahashi, Noriyuki; Takehana, Nobuaki; Osaka, Naoya; Sugita, Hiroe; Terasaki, Michishige; Mori, Yusaku; Fukui, Tomoyasu; Yamagishi, Sho-Ichi

Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study

二肽基肽酶4抑制剂换用口服索玛鲁肽对2型糖尿病患者氧化应激和血糖波动的影响:一项开放标签、前瞻性、随机、多中心、平行组比较研究

Ohara, Makoto; Yokoyama, Hiroki; Seino, Hiroaki; Fujikawa, Tomoki; Kohata, Yo; Takahashi, Noriyuki; Irie, Shunichiro; Terasaki, Michishige; Mori, Yusaku; Fukui, Tomoyasu; Yamagishi, Sho-Ichi

A Clinical Case of Probable Sitosterolemia

疑似谷甾醇血症的临床病例

Terasaki, Michishige; Izumi, Mikiko; Yamagishi, Sho-Ichi

Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study

注射用索玛鲁肽和度拉糖肽对2型糖尿病患者氧化应激和血糖变异性影响的比较:一项前瞻性初步研究

Omachi, Takemasa; Ohara, Makoto; Fujikawa, Tomoki; Kohata, Yo; Sugita, Hiroe; Irie, Shunichiro; Terasaki, Michishige; Mori, Yusaku; Fukui, Tomoyasu; Yamagishi, Sho-Ichi

Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation

葡萄糖依赖性胰岛素促泌多肽部分通过激活 AMPK 抑制巨噬细胞中 AGE 诱导的 NADPH 氧化酶衍生的氧化应激产生和泡沫细胞形成

Michishige Terasaki, Hironori Yashima, Yusaku Mori, Tomomi Saito, Naoto Inoue, Takanori Matsui, Naoya Osaka, Tomoki Fujikawa, Makoto Ohara, Sho-Ichi Yamagishi